What's New

Medical News
& Alerts

Conferences
& Meetings


Other Medical
Resources

Employment
Opportunities

Partnering
Opportunities

Search results for: Alza
97%DGNews: Efidac 24 Combination Cold/Allergy Medication Cleared by FDA
96%DGNews: Approvable Letter Received for Covera-hs(tm)
93%DGNews: Canada Approves Ditropan XL (Oxybutynin Chloride) for Overactive Bladder
93%DGNews: AAN: Concerta (methylphenidate HCl) ER improves attention, behaviour in ADD/ADHD
93%DGNews: FDA Approves Viadur (Leuprolide) Implant For Advanced Prostate Cancer
93%DGNews: UK Approves Ditropan XL (Oxybutynin) For Urinary Incontinence
93%DGNews: Ethyol Approved for Marketing in Canada
93%DGNews: DynaCirc CR Once-Daily Calcium Channel Blocker Launched
92%DGNews: PAS/AAP: Extended Release Concerta (Methylphenidate) As Effective as More Frequent Dosing
92%DGNews: Ethyol Now Available Nationwide
92%DGNews: Testoderm Patch Cleared In U.S. For Testosterone Deficiency
91%DGNews: AUA MEETING: Ditropan XL Effective In Reducing Urinary Incontinence
91%DGNews: Ethyol Receives Additional Indication for Non-Small Cell Lung Cancer
90%DGNews: FDA Advisors Recommend Doxil For Refractory Ovarian Cancer
90%DGNews: Testoderm Patch Now Available For Testosterone Deficiency
89%DGNews: Fentanyl 25 mcg Patches Recalled
89%DGNews: AACAP: Concerta May Provide Once-Daily Treatment For ADD/ADHD
88%DGNews: WHOCI: Oxybutynin Extended-Release Provides Steady Delivery In Varying pH Levels
88%DGNews: Once-Daily Concerta (Methylphenidate) For Attention Deficit Hyperactivity Disorder Approved In US
88%DGNews: Ditropan XL Reduces Urge Incontinence Episodes By 85%
87%DGNews: ICS MEETING: Ditropan XL Effective In The Treatment Of Overactive Bladder
87%DGNews: Covera-HS for Hypertension and Angina Now Available
87%DGNews: Ditropan XL Approved For Treatment Of Overactive Bladder
86%DGNews: Study Shows Positive Results for Novel, Patient-Controlled Transdermal System for Acute Postoperative Pain Control
86%DGNews: Ditropan XL (Oxybutynin Chloride) Effective In Reducing Urge Incontinence And Urinary Frequency
86%DGNews: Clear NicoDerm CQ Now Available In US
86%DGNews: Nicoderm Cq Approved for Over-the-Counter Use
86%DGNews: AGS: Ditropan XL (Oxybutynin) Once Daily Helps Elderly Patients With Overactive Bladders
86%DGNews: FDA Panel Recommends Ethyol For Radiation-Induced Xerostomia
86%DGNews: FDA Approves Ethyol To Reduce Radiation-Induced Dry Mouth
86%DGNews: Doxil Approved For Refractory Ovarian Cancer
86%DGNews: DG DISPATCH - AUA: Extended Release Ditropan Causes Less Dry Mouth
86%DGNews: ACOG MEETING: Ditropan XL Reduces Incontinence Episodes By 81%
85%DGNews: European Commission Approves Ionsys (Fentanyl HCl Iontophoretic Transdermal System) for Acute Post-operative Pain
85%DGNews: FDA Grants Priority Review To Doxil For Refactory Ovarian Cancer
84%DGNews: ALZA Corporation Receives FDA Approval for Ionsys (Fentanyl Iontophoretic Transdermal System)
84%DGNews: Caelyx (Pegylated Liposomal Doxorubicin Hydrochloride) Approved In Europe For Advanced Ovarian Cancer
84%DGNews: Searle's Covera-HS Receives Marketing Clearance by FDA
84%DGNews: AUA MEETING: Duros Implant Suppresses Testosterone In Men With Prostate Cancer
83%DGNews: IARS: Transdermal Device Compares Well with IV Patient Controlled Analgesia
83%Conference: Oncology Nursing Society
83%Conference: Oncology Nursing Society
83%Conference: Oncology Nursing Society
82%DGNews: ACOG: Overactive Bladder Drugs Appear Safe; Oxybutynin Outperforms Tolterodine
82%Conference: Oncology Nursing Society
82%Conference: Oncology Nursing Society
82%Conference: Oncology Nursing Society
82%Conference: Oncology Nursing Society
82%DGNews: Ditropan XL Now Available In U.S. For Overactive Bladder
81%DGNews: Study Suggests That Investigational Drug Paliperidone ER Improves Sleep Onset, Continuity and Duration in Clinical Study of Schizophrenia Patients With Insomnia
Enter keywords you wish to find information about:

Search for documents that contain:
any of these words.
this exact phrase.
all of these words.

 

 

This site is maintained by webmaster@pslgroup.com
Please contact us with any comments, problems or bugs.

All contents Copyright (c) 1998 PSL Consulting Group Inc.
all rights reserved.